Answers are grounded in this paper and cite their sources.
GLI1 is a transcriptional regulator involved in the development of different types of cancer. GLI1 transcriptional activity is regulated within the Hedgehog pathway (canonical activity), but can also be controlled independently (non-canonical activity) in the context of other signaling pathways. Experimental evidences show GLI1 involvement in both small- and non-small-cell lung cancers. Direct inhibition of the protein, in combination with other chemotherapeutic agents, represents a promising strategy for the treatment of different malignancies.
No takes yet. Share an insight, caveat, or question.
Mastrangelo et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: